PAR:DBV

DBV Technologies S.A. Stock Predictions

Euronext Paris > Healthcare > Biotechnology

Open Broker Account

0.95€

-0.0360 (-3.65%)

At Close: Jun 14, 2024

Currently predicting for Tue, 18 Jun 2024

Trading levels for DBV.PA

Fibonacci Support & Resistance Levels

Level	Price
R3	1.02	7.36%
R2	0.99	4.43%
R1	0.98	2.62%
Price	0.95
S1	0.92	-3.25%
S2	0.90	-5.06%
S3	0.88	-7.99%

Accumulated Volume Support & Resistance Levels

Level	Price
R3	1.10	15.25%
R2	1.05	10.41%
R1	1.00	4.63%
Price	0.95
S1	0	-
S2	0	-
S3	0	-

DBV.PA Predictions History

3 years ago
Joe Hattab predicted that DBV.PA for 2021-03-11 is going 10.01€ (9.04%)

Rank:

About DBV Technologies S.A.

DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. Its lead product candidate is Viaskin Peanut, an immunotherapy product, which has completed Phase III clinical trial for the treatment of peanut allergies in 4 to 11 years of age children, adolescents, and adults. The milk-induced company is also developing Viaskin Milk that is in Phase I/II clinical t... DBV.PA Profile

Golden Star

Ticker	Date	Change	Price
LIN	Jun 12	0.640%	$434.17
BNDX	Jun 12	0.637%	$48.64
MAIN	Jun 12	0.673%	$49.01
EQR	Jun 11	1.77%	$65.55
RPM	Jun 11	0.92%	$110.28
FR	Jun 11	1.52%	$46.78
CAH	Jun 11	1.20%	$99.01
ESI	Jun 11	11.50%	$23.73
FTGC	Jun 11	0.374%	$24.09
FTSM	Jun 11	0.0838%	$59.68

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by

Sign In